Fast visual discovery for photos, concepts, and creative inspiration.

Explore

Home
Discover Boards
Trending Search

Account

Sign In
Create Account
Saved Images
My Boards

© 2026 Mungart. All rights reserved.

Built for speed, clarity, and visual exploration.

…

Ly3502970 Development

Family-friendly

SizeAspectAccentType

Showing 116 of 116on this page. Filters & sort apply to loaded results; URL updates for sharing.116 of 116 on this page

LY3502970 (Orforglipron) | GLP-1 agonist | Probechem Biochemicals

LY3502970 binding and the conformation of TM1, TM2, and TM7 of the ...

Ly3502970 | 2212020-52-3

LY3502970 binding and the conformation of TM1, TM2, and TM7 of the ...

GLP1R PAM virtual screen. LY3502970 Analogs.

LY3502970 binding and the conformation of TM1, TM2, and TM7 of the ...

LY3502970 binding and the conformation of TM1, TM2, and TM7 of the ...

GLP1R PAM virtual screen. LY3502970 Analogs.

Estudio sobre el efecto de LY3502970 en adultos con obesidad o ...

GLP1R PAM virtual screen. LY3502970 Analogs.

GLP1R PAM virtual screen. LY3502970 Analogs.

Embryo Development Timeline

Sustainable Development Report 2025, India Rank, Highlights

GLP1R PAM virtual screen. LY3502970 Analogs.

LY3502970 (Orforglipron)|CAS 2212020-52-3|DC Chemicals

Retrosynthetic Strategy for Orforglipron (LY3502970) Using ChemAIRS, a ...

Retrosynthetic Strategy for Orforglipron (LY3502970) Using ChemAIRS, a ...

创新药新事：“简单”改一个专利分子结构，价值20亿美元 - 知乎

(PDF) Structural basis for GLP-1 receptor activation by LY3502970, an ...

Retrosynthetic Strategy for Orforglipron (LY3502970) Using ChemAIRS, a ...

礼来和辉瑞等争夺下一个黄金赛道

Orforglipron (LY3502970) | GLP-1R Agonist | MedChemExpress

(PDF) Structural basis for GLP-1 receptor activation by LY3502970, an ...

Retrosynthetic Strategy for Orforglipron (LY3502970) Using ChemAIRS, a ...

减肥药厂商比减肥患者更焦虑 | 见智研究

CAS: 2212020-52-3| Orforglipron（LY3502970）|HI-FUTURE

SNAC-“减肥药”最核心的一环-韭研公社

奥氟格列隆|Orforglipron|LY3502970|OWL833——药研档案

创新药周报：LY3502970启动III期，关注GLP1RA小分子研发进展

医药魔方

口服小分子GLP-1R激动剂，下一个现金牛？

Structural basis for GLP-1 receptor activation by LY3502970, an orally ...

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like ...

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

Orforglipron|LY3502970|OWL833——药研档案

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

52-OR: Effect of Oral Nonpeptide GLP-1 Receptor Agonist Orforglipron ...

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like ...

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like ...

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin ...

Orforglipron (LY3502970) | GLP-1R Agonist | CAS 2212020-52-3 | Selleck ...

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

Orforglipron | Drug Information, Uses, Side Effects, Chemistry ...

(PDF) Structural basis for GLP-1 receptor activation by LY3502970, an ...

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like ...

礼来GLP-1R激动剂LY3502970在中国启动3期临床 - 知乎

Effect of Food Consumption on the Pharmacokinetics, Safety, and ...

769-P: Effect of Food on the Pharmacokinetics, Safety, and Tolerability ...

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like ...

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

奥氟格列隆|Orforglipron|LY3502970|OWL833——药研档案

礼来GLP-1R激动剂LY3502970在中国启动3期临床 - 知乎

全球首个！礼来口服小分子GLP-1R激动剂启动III期临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方

52-OR: Effect of Oral Nonpeptide GLP-1 Receptor Agonist Orforglipron ...

GLP-1R小分子激动剂转向？倒车接人？--辉瑞开启新分子I期临床 - 知乎

Orforglipron (LY3502970) | GLP-1R Agonist | MedChemExpress

礼来口服GLP-1R激动剂LY3502970在中国启动3期临床，减重效果显著

Orforglipron | 奥格列隆 | GLP-1受体激动剂 | TargetMol

Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and ...

小分子GLP-1RA：辉瑞放弃第二代，继续推进第一代 Armstrong 2023年6月26日，辉瑞更新了小分子GLP-1R激动剂项目的 ...

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

礼来GLP-1R激动剂LY3502970在中国启动3期临床 - 知乎

Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like ...

Orforglipron (LY3502970) | GLP-1R Agonist | MedChemExpress

Effect of Food Consumption on the Pharmacokinetics, Safety, and ...

Orforglipron (CAS 2212020-52-3)

Efficient transfected liposomes co-loaded with pNrf2 and pirfenidone ...

Orforglipron (LY3502970) | GLP-1R Agonist | MedChemExpress

orforglipron | Ligand page | IUPHAR/BPS Guide to PHARMACOLOGY

礼来和辉瑞等争夺下一个黄金赛道

(PDF) Effect of Food Consumption on the Pharmacokinetics, Safety, and ...

类风关III期临床启动，利妥昔多适应症研发进入尾声

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like ...

Analysis of Time-Dependent Pharmacokinetics Using In Vitro–In Vivo ...

【13期】TargetMol明星分子——Orforglipron - 知乎

礼来GLP-1R激动剂LY3502970在中国启动3期临床 - 知乎

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

Affinity selection of double-click triazole libraries for rapid ...

WIKIMOLE—Orforglipron

礼来口服GLP-1R激动剂LY3502970在中国启动3期临床，减重效果显著

Affinity selection of double-click triazole libraries for rapid ...

礼来口服GLP-1R激动剂LY3502970在中国启动3期临床，减重效果显著

礼来口服GLP-1R激动剂申报临床，治疗2型糖尿病和肥胖 3月22日，CDE官网显示，礼来 LY3502970胶囊的临床试验申请已获药监局 ...

专利唐律说 | “简单”改一个专利分子结构，价值20亿美元 - 知闻 ZHI WEN

The pharmacological basis for nonpeptide agonism of the GLP-1 receptor ...

礼来口服GLP-1R激动剂LY3502970在中国启动3期临床，减重效果显著

Structural basis for GLP-1 receptor activation by LY3502970, an orally ...

全球创新药新进展！安斯泰来首款眼科药物获批上市 - 知乎

Orforglipron (LY3502970) | GLP-1R激动剂 | MCE

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

RCSB PDB - 6XOX: cryo-EM of human GLP-1R bound to non-peptide agonist ...

The inhibitory potency in IC50 or EC50, cytotoxicity, and selectivity ...

GLP-1R Signaling and Functional Molecules in Incretin Therapy

创新药周报：AD领域进展不断，关注抗体+小分子

Orforglipron (LY3502970): Benefits, Dosing, Side Effects, & More | Jay ...

Orforglipron Mechanism of Action: How It Works

礼来口服GLP-1R激动剂LY3502970在中国启动3期临床，减重效果显著

礼来口服GLP-1R激动剂LY3502970在中国启动3期临床，减重效果显著

礼来口服GLP-1R激动剂LY3502970在中国启动3期临床，减重效果显著

礼来GLP-1R激动剂LY3502970在中国启动3期临床 - 知乎

【13期】TargetMol明星分子——Orforglipron - 知乎

RCSB PDB - 6XOX: cryo-EM of human GLP-1R bound to non-peptide agonist ...

Investigating Potential GLP-1 Receptor Agonists in Cyclopeptides from ...

(PDF) Structural basis for GLP-1 receptor activation by LY3502970, an ...

RCSB PDB - 6XOX: cryo-EM of human GLP-1R bound to non-peptide agonist ...

RCSB PDB - 6XOX: cryo-EM of human GLP-1R bound to non-peptide agonist ...

The overall cryo-EM structure of GLP-1R–Gs complexes The cryo-EM maps ...

Orforglipron (LY3502970) | GLP-1R激动剂 | MCE

RCSB PDB - 6XOX: cryo-EM of human GLP-1R bound to non-peptide agonist ...

Orforglipron (LY3502970) | GLP-1R激动剂 | MCE

Structural analysis of the WB4-24-bound GLP-1R. (A) Structural ...

RCSB PDB - 6XOX: cryo-EM of human GLP-1R bound to non-peptide agonist ...

RCSB PDB - 6XOX: cryo-EM of human GLP-1R bound to non-peptide agonist ...

RCSB PDB - 6XOX: cryo-EM of human GLP-1R bound to non-peptide agonist ...

People also searched

Ly3502970 Mice Ly3502970 Preclinical Ly3502970 Structure Ly3502970 Monkey Orforglipron Ly3502970 Ly3502970 Synthesis Ly3502970 Semaglutide Ly3502970 PPT Preclinical Data of Ly3502970 Ly3502970 GIP Amylin Ly3502970 Capsules 礼来临床试验 Ly3502970 Metabolite Ly3502970 and Tirzepatide Ly3502970 and Danuglipron Orforglipron Ly3502970 Clinical Trials Orforglipron Ly3502970 CASNo Ly3502970 Route 临床剂量 Ly3502970 Ly3502970 Dio Mouse Orforglipron Ly3502970 Dio Mice 临床试验 Ly3502970 Orforglipron or Ly3502970 Dio Mice 临床 Ly3502970 Ly3502970 Humanized GLP-1 Mice Ly3502970 Pharmacokinetic Orforglipron Ly3502970 Mice Ly3502970 Mouse Ly3502970 Trough Ly3502970 Clinical Trial A Study of Ly3502970 in Participants with Type 2 Diabetes Mellitus Ly3502970 Pharmacokinetics Ly3502970 Phase 2 Orforglipron Ly3502970 Route of Synthesis Ly3502970 Poster Ly3502970 Phase 1 Ly3502970 Internalization Ly3502970 Plasma Ly3502970 Dio Mice Ly3502970 Phase 1 Results